Egg donation in 2026: what two landmark studies mean for your treatment plan

Egg donation is one of the most common reasons people travel for fertility care — often because waiting lists at home are long, donor availability is limited, or the cost of repeated cycles is out of reach. Two studies published this spring in the field’s leading journals speak directly to patients in that situation. Neither is a reason for alarm; both are reasons to ask better questions.

Study 1: how the uterus is prepared matters more than many clinics assume

Before a frozen embryo is transferred, the recipient’s uterine lining has to be ready. Clinics do this one of two ways: an artificial (hormone-replacement) cycle, where estrogen and progesterone are given on a schedule, or a natural cycle, which follows the woman’s own ovulation and adds progesterone support. The artificial cycle is popular because it is predictable — useful when patients and clinics are coordinating across borders.

In April 2026, the IVIRMA Global Research Alliance published in Human Reproduction the largest comparison to date in donor-egg recipients: 67,048 single-blastocyst transfers performed between 2010 and 2023 across Spain and Portugal — 6,922 in natural cycles and 60,126 in artificial cycles.

The natural-cycle group did better on nearly every measure that matters:

• Higher live birth rate (adjusted odds ratio 1.38)
• Lower miscarriage rate after a positive test (adjusted OR 0.68)
• Fewer hypertensive disorders of pregnancy (adjusted OR 0.72)
• Fewer caesarean deliveries (adjusted OR 0.86) and fewer large-for-gestational-age babies (adjusted OR 0.77)

Importantly, the advantage held regardless of the recipient’s age. The study is retrospective, so it cannot prove cause and effect on its own, but it is consistent with a growing body of evidence that the corpus luteum — the structure that forms after natural ovulation — produces substances that support early pregnancy and placental health in ways a hormone schedule does not fully replicate.

Study 2: donor-egg pregnancies need closer blood-pressure follow-up

A week earlier, in Human Reproduction Update, the DONOR consortium led by Leiden University Medical Center pooled individual patient data from 16 cohorts: 2,747 egg-donation pregnancies, 4,699 pregnancies from IVF with the woman’s own eggs, and 33,323 natural conceptions.

Hypertensive complications (high blood pressure in pregnancy, including preeclampsia) occurred in 18.2% of egg-donation pregnancies, compared with 10.9% after conventional IVF and 4.5% after natural conception. After adjusting for age and other factors, the odds of any hypertensive complication were about 2.9 times higher with donor eggs, and the odds of preeclampsia about 2.4 times higher — findings the authors rated as high-certainty. The risk was present across subgroups. The authors also noted a possible protective effect of low-dose aspirin that still needs confirmation in trials.

This is not new in kind — clinicians have long known that donor-egg pregnancies carry extra immunological load — but it is the clearest quantification yet, and it turns a vague warning into a concrete plan.

What to do with this if you are planning donor-egg IVF abroad

Ask your clinic whether it offers natural-cycle preparation for donor-egg recipients, and if so, how it handles the logistics for an international patient. Natural cycles require monitoring of ovulation, which can mean a slightly longer stay or coordinated monitoring with a doctor at home before you travel. A clinic that has thought this through will tell you exactly how it works. A clinic that only offers the artificial protocol “because it is easier to schedule” is prioritizing its calendar over the evidence.

Tell your obstetrician at home that the pregnancy came from donor eggs. This single sentence changes how your prenatal care should be managed: closer blood-pressure monitoring, a discussion about low-dose aspirin (a decision for your doctor, not a blog), and a lower threshold for investigating symptoms of preeclampsia. Ask the clinic abroad for a written summary of your treatment you can hand over.

Do not read the preeclampsia numbers as a reason against egg donation. Most donor-egg pregnancies are healthy. The point is that knowing your risk category lets your care team watch the right things.

Why this matters for patients choosing Mexico

Egg donation is a significant part of why international patients come to Mexico, and the clinics that serve them well are the ones that engage with this kind of evidence — offering natural-cycle protocols, explaining the trade-offs honestly, and sending patients home with documentation their obstetrician can use. When you compare clinics, these two studies give you a short, specific test of whether a program is keeping up with the science.

For a step-by-step view of how a donor-egg cycle fits into a treatment trip, see the patient journey.